Your browser doesn't support javascript.
loading
Neoadjuvant Camrelizumab for Non-Small Cell Lung Cancer: A Retrospective Multicenter, Real-World Study (CTONG2004).
Liu, Si-Yang; Chen, Qixun; Zhou, Chengzhi; Zhang, Huizhong; Li, Wen; Chen, Jianhua; Hu, Jian; Wu, Lin; Chen, Qunqing; Dai, Qiangsheng; Shan, Jian-Zhen; Xu, Fei; Liu, Si-Yang Maggie; Wu, Yi-Long.
Afiliação
  • Liu SY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China.
  • Chen Q; Department of Thoracic Oncological Surgery, Cancer Hospital of The University of Chinese Academy of Sciences, Hangzhou, 310022, People's Republic of China.
  • Zhou C; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510120, People's Republic of China.
  • Zhang H; Department of Thoracic Surgery, SUN YAT-SEN Memorial Hospital, SUN YAT-SEN University, Guangzhou, 510123, People's Republic of China.
  • Li W; Department of Respiratory Medicine, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, People's Republic of China.
  • Chen J; Department of Thoracic Medical Oncology, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, People's Republic of China.
  • Hu J; Department of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, People's Republic of China.
  • Wu L; Second Department of Thoracic Medicine, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, People's Republic of China.
  • Chen Q; Department of Thoracic Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, People's Republic of China.
  • Dai Q; Department of Medical Oncology, The First Affiliated Hospital, SUN YAT-SEN University, Guangzhou, 510060, People's Republic of China.
  • Shan JZ; Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, People's Republic of China.
  • Xu F; Department of Respiratory Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, 330209, People's Republic of China.
  • Liu SM; Department of HematologyFirst Affiliated HospitalInstitute of Hematology, School of MedicineKey Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, 510632, People's Republic of China. siyangliu2020@outlook.com.
  • Wu YL; Chinese Thoracic Oncology Group (CTONG), Guangzhou, 510055, People's Republic of China. siyangliu2020@outlook.com.
Cancer Immunol Immunother ; 72(7): 2257-2265, 2023 Jul.
Article em En | MEDLINE | ID: mdl-36871274
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article